(RTTNews) - Kite, a Gilead Company (GILD), announced the primary overall survival analysis results of the Phase 3 ZUMA-7 study. The results showed a statistically significant improvement for Yescarta ...

An analysis of accounts on social media platform X that have been used to promote Russian interests in South Africa are now being utilized to rally support for a new party backed by former President ...

Long-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 Study Axicabtagene ciloleucel (axi-cel) is ...